Design Therapeutics, Inc. (DSGN) vs InMode Ltd. (INMD)
A side-by-side comparison of Design Therapeutics, Inc. and InMode Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DSGN
Design Therapeutics, Inc.
$12.16HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
INMD
InMode Ltd.
$14.01HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
Total return — DSGN vs INMD
growth of $100 · dividends reinvested · last 6yDSGN -70.1% (-18.2%/yr)INMD -58.3% (-13.6%/yr)INMD compounded faster over this window
DSGN INMD
DSGN vs INMD: by the numbers
- •INMD is the larger company ($805M vs $759M market cap).
- •INMD is profitable (20.69% net margin) while DSGN runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | DSGN | INMD |
|---|---|---|
| P/E ratio | N/A | 11.39 |
| Forward P/E | N/A | 10.81 |
| PEG ratio | N/A | 1.14 |
| P/S ratio | N/A | 2.15 |
| P/B ratio | 3.76 | 1.28 |
| EV / EBITDA | N/A | 5.92 |
| FCF yield | N/A | 10.86% |
Profitability
| Metric | DSGN | INMD |
|---|---|---|
| Gross margin | 0.00% | 76.52% |
| Operating margin | 0.00% | 18.47% |
| Net margin | 0.00% | 20.69% |
| ROE | -35.07% | 12.32% |
| ROIC | -38.92% | 9.20% |
Growth (annualized)
| Metric | DSGN | INMD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 5.42% |
| EPS CAGR (5Y) | N/A | 6.87% |
| FCF CAGR (5Y) | N/A | 1.36% |
| Total return CAGR (5Y) | -3.82% | -27.48% |
Frequently asked
- Is DSGN or INMD more profitable?
- INMD runs the higher net margin — DSGN at 0.00% versus INMD at 20.69%.
- How have DSGN and INMD total returns compared?
- Over the past 5 years, DSGN delivered -3.82% and INMD delivered -27.48% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
InMode P/E ratioDesign Therapeutics ROEInMode ROEDesign Therapeutics operating marginInMode operating marginDesign Therapeutics revenue growthInMode revenue growthDesign Therapeutics free cash flowInMode free cash flow
Design Therapeutics & InMode appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.